Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for fatigue during adjuvant radiotherapy and chemotherapy in breast cancer
IRCT20180426039421N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cancer-related fatigue (CRF) comparing Melatonin with Placebo control (2 arms). Primary endpoints: Fatigue severity, Type of treatment and 3 more. Started Oct 2018; status: completed.
02
Drugs
melatonin
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on IRCT20180426039421N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180426039421N1.